Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp

May 7, 2013 11:41 AM EDT Send to a Friend
Shares of Synta Pharma. (NASDAQ: SNTA) are lower on Tuesday, a moved tied to the resignation of the company's R&D ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login